Sheridan William P
Chief Medical Officer at BCRX
- Sold, on record
- $9.7M
- Dollars the filings state
- Form 4 sales
- 14
- Latest Mar 10, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- BCRXBIOCRYST PHARMACEUTICALS INCChief Medical Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale BCRXUnusualJun 19, 2015 2015
Sold 70,389 shares at $15.05 ($1.1M)
Sheridan William P, Senior VP - CMO
Sold 42.5% of holdings ($2.5M position)95,123 shares leftFiling
- 2 Form 4 sale BCRXUnusualNov 13, 2017 +878 days
Sold 64,310 shares at $4.72 ($304k)
Sheridan William P, Senior VP - CMO
Sold 72.9% of holdings ($416k position)23,855 shares leftFirst sale on recordFiling
- 3 Form 4 sale BCRXUnusualJun 1, 2018 +200 days
Sold 42,112 shares at $6.30 ($265k)
Sheridan William P, Senior VP - CMO
Sold 66.7% of holdings ($398k position)21,058 shares leftFiling
- 4 Form 4 sale BCRXUnusualAug 9, 2018 +69 days
Sold 62,500 shares at $7.03 ($439k)
Sheridan William P, Senior VP - CMO
Sold 72.9% of holdings ($603k position)23,213 shares leftFiling
- 5 Form 4 sale BCRXUnusualDec 18, 2018 +131 days
Sold 20,488 shares at $7.58 ($155k)
Sheridan William P, Senior VP - CMO
Sold 88.3% of holdings ($176k position)2,725 shares left0.3x usual sizeFiling
- 6 Form 4 sale BCRXUnusualFeb 22, 2021 +797 days
Sold 41,250 shares at $11.57 ($477k)
Sheridan William P, Senior VP - CMO
Sold 78.2% of holdings ($610k position)11,475 shares leftFirst sale on recordFiling
- 7 Form 4 sale BCRXUnusualMay 28, 2021 +95 days
Sold 163,573 shares at $15.01 ($2.5M)
Sheridan William P, Chief Medical Officer
Sold 91.9% of holdings ($2.7M position)14,475 shares leftFiling
- 8 Form 4 sale BCRXUnusualMar 10, 2022 +286 days
Sold 161,139 shares at $16.88 ($2.7M)
Sheridan William P, Chief Medical Officer
Sold 80.9% of holdings ($3.4M position)37,954 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (14)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 10, 2022 | Mar 14, 2022 | BCRX | Chief Medical Officer | Form 4 sale | 161,139 | $2.7M | 80.9% | Unusual | SEC |
| May 28, 2021 | Jun 1, 2021 | BCRX | Chief Medical Officer | Form 4 sale | 163,573 | $2.5M | 91.9% | Unusual | SEC |
| Feb 22, 2021 | Feb 24, 2021 | BCRX | Senior VP - CMO | Form 4 sale | 41,250 | $477k | 78.2% | Unusual | SEC |
| Dec 18, 2018 | Dec 20, 2018 | BCRX | Senior VP - CMO | Form 4 sale | 20,488 | $155k | 88.3% | Unusual | SEC |
| Aug 9, 2018 | Aug 13, 2018 | BCRX | Senior VP - CMO | Form 4 sale | 62,500 | $439k | 72.9% | Unusual | SEC |
| Jun 1, 2018 | Jun 5, 2018 | BCRX | Senior VP - CMO | Form 4 sale | 42,112 | $265k | 66.7% | Unusual | SEC |
| Nov 13, 2017 | Nov 15, 2017 | BCRX | Senior VP - CMO | Form 4 sale | 64,310 | $304k | 72.9% | Unusual | SEC |
| Jun 19, 2015 | Jun 22, 2015 | BCRX | Senior VP - CMO | Form 4 sale | 70,389 | $1.1M | 42.5% | Unusual | SEC |
| Dec 30, 2014 | Dec 31, 2014 | BCRX | Senior VP - CMO | Form 4 sale | 128,399 | $1.6M | 58.1% | Unusual | SEC |
| Mar 2, 2012 | Mar 5, 2012 | BCRX | SR VP - CMO | Form 4 sale | 956 | $5k | 3.2% | Plan not stated | SEC |
| Apr 8, 2010 | Apr 12, 2010 | BCRX | SR VP - CMO | Form 4 sale | 18,593 | $149k | 91.8% | Unusual | SEC |
| Jan 11, 2010 | Jan 12, 2010 | BCRX | SR VP - CMO | Form 4 sale | 4,166 | $34k | 100.0% | Unusual | SEC |
| Dec 1, 2009 | Dec 2, 2009 | BCRX | SR VP - CMO | Form 4 sale | 4,167 | $34k | 100.0% | Unusual | SEC |
| Oct 14, 2009 | Oct 15, 2009 | BCRX | SR VP - CMO | Form 4 sale | 6,000 | $54k | 100.0% | Unusual | SEC |